Olanzapine-induced diabetic ketoacidosis in a Chinese man

Hong Kong Medical Journal

Volumn 13, Issue 1, 2007, Pages 73-74

  Wong, Jessica O Y ^a   Fu, Jackie C K ^a   Hung, Gabriel B K ^a  

^a CASTLE PEAK HOSPITAL   (Hong Kong)

Author keywords

Diabetic ketoacidosis; Olanzapine; Schizophrenia

Indexed keywords

CARBAMAZEPINE; HALOPERIDOL; INSULIN; MONOCOMPONENT INSULIN; OLANZAPINE; RISPERIDONE; VALPROIC ACID;

ADULT; ARTICLE; CASE REPORT; CHINESE; DIABETIC KETOACIDOSIS; DIET RESTRICTION; DISSOCIATIVE DISORDER; DRUG WITHDRAWAL; FATIGUE; GLUCOSE BLOOD LEVEL; HEART MUSCLE ISCHEMIA; HUMAN; LABORATORY TEST; LIVER FUNCTION; MALE; NAUSEA; PERSONALITY DISORDER; PHYSICAL EXAMINATION; SCHIZOPHRENIA; SIDE EFFECT; VOMITING;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DIABETIC DIET; DIABETIC KETOACIDOSIS; HONG KONG; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; SCHIZOPHRENIA;

EID: 33947596470     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Dixon L, Weiden P, Delahanty J, et al. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull 2000;26:903-12.
2. Sernyak MJ, Leslie DL, Alarcon RD, Losonczy MF, Rosenheck R. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry 2002;159:561-6.
3. Wirshing DA, Spellberg BJ, Erhart SM, Marder SR, Wirshing WC. Novel antipsychotics and new onset diabetes. Biol Psychiatry 1998;44:778-83.
4. Koro CE, Fedder DO, L'Italien GJ, et al. Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study. BMJ 2002;325:243.
5. Gianfrancesco FD, Grogg AL, Mahmoud RA, Wang RH, Nasrallah HA. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database. J Clin Psychiatry 2002;63:920-30.
6. Leslie DL, Rosenheck RA. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. Am J Psychiatry 2004;161:1709-11.
7. Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209-23.
8. Lindenmayer JP, Patel R. Olanzapine-induced ketoacidosis with diabetes mellitus. Am J Psychiatry 1999;156:1471.
9. Goldstein LE, Sporn J, Brown S, et al. New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment. Psychosomatics 1999;40:438-43.
10. Muench J, Carey M. Diabetes mellitus associated with atypical antipsychotic medications: new case report and review of the literature. J Am Board Fam Pract 2001;14:278-82.
11. Seaburg HL, McLendon BM, Doraiswamy PM. Olanzapine-associated severe hyperglycemia, ketonuria, and acidosis: case report and review of literature. Pharmacotherapy 2001;21:1448-54.
12. Wilson DR, D'Souza L, Sarkar N, Newton M, Hammond C. New-onset diabetes and ketoacidosis with atypical antipsychotics. Schizophr Res 2003;59:1-6.
13. Tsuchiyama N, Ando H, Ota T, Sakurai M, Takamura T. Modulating effects of olanzapine on the development of diabetic ketoacidosis. Diabet Med 2004;21:300-1.
14. Straker D, Mendelowitz A, Karlin L. Near fatal ketoacidosis with olanzapine treatment. Psychosomatics 2002;43:339-40.
15. Melkersson KI, Hulting AL, Brismar KE. Elevated levels of insu-lin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. J Clin Psychiatry 2000;61:742-9.